Ignite Creation Date:
2025-12-25 @ 1:39 AM
Ignite Modification Date:
2025-12-25 @ 11:55 PM
Study NCT ID:
NCT04723394
Status:
COMPLETED
Last Update Posted:
2023-07-05
First Post:
2021-01-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase III Study of AZD7442 for Treatment of COVID-19 in Outpatient Adults
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-01-28
Start Date Type:
ACTUAL
Primary Completion Date:
2021-08-21
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-10-19
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-14
First Submit QC Date:
None
Study First Post Date:
2021-01-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-08-17
Results First Submit QC Date:
None
Results First Post Date:
2022-12-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-06-30
Last Update Post Date:
2023-07-05
Last Update Post Date Type:
ACTUAL